NextGen Group

The American Society for Mass Spectrometry has named University of Wisconsin-Madison researcher Josh Coon winner of its Klaus Biemann Medal.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – UK-based NextGen Group announced this week it has completed the formation of a diagnostics subsidiary to develop tests for central nervous system disorders.

This story originally ran on Feb. 2.
Protein biomarker firm NextGen Group said this week that it has entered a convertible loan agreement with Alpha 4 Concepts for the provision of additional funding of €800,000 ($1.05 million).

Citing lower than expected sales in its biomarker and testing business, protein biomarker firm NextGen Group said this week it has entered a convertible loan agreement with Alpha 4 Concepts for the provision of additional funding of £650,000 ($1.04 million).

This story has been updated to correct a statement regarding H1 revenues from NextGen's biomarker qualification panels.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.